Jci_page_head_homepage_01 Jci_page_head_homepage_02
Michelle Welsh, Philippa T.K. Saunders, Mark Fisken, Hayley M. Scott, Gary R. Hutchison, Lee B. Smith, Richard M. Sharpe
Published in Volume 118, Issue 4
J Clin Invest. 2008; 118(4):1479–1490 doi:10.1172/JCI34241
Abstract | Full text | PDF
Options: View larger image (or click on image)
Medium
Figure 2
Reproductive congenital abnormalities can only be induced by impaired androgen action in the early programming window.

Male rats exposed in utero to flutamide in EW (E15.5–E17.5), MW (E17.5–E19.5), LW (E19.5–E21.5), or FW (E15.5–E21.5) were examined at P25 for hypospadias and cryptorchidism. (A) Images of external genitalia in P25 males demonstrating normal AGD (line) and penis formation, with the urethral opening (arrowhead) at the tip, and scrotal testes (S) in control males compared with reduced AGD, abnormal penis formation with a urethral opening at the base, and undescended testes in EW or FW flutamide-exposed males. Original magnification, ×1.4. (B) Note that EW or MW flutamide induced hypospadias, as evidenced in A by the slit-like opening on the ventral surface of the penis (arrow), while FW-flutamide exposure resulted in a phallus with a female phenotype. (C) Schematic diagram of the phases of normal testis descent. (D) Incidence of cryptorchidism, showing that it can only be induced by flutamide exposure during the EW. Reduced AGD predicted the severity of hypospadias (E) and the incidence of cryptorchidism (F), as well as correlating with reduced penis length (G). Values are mean ± SEM (n = 8–28 rats from 2–5 litters per treatment group). ***P < 0.001 compared with control male values.